Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

125 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Nail toxicity due to the combination adriamycin-mitoxantrone.
Van Belle SJ, Dehou MF, De Bock V, Volckaert A. Van Belle SJ, et al. Cancer Chemother Pharmacol. 1989;24(1):69-70. doi: 10.1007/BF00254111. Cancer Chemother Pharmacol. 1989. PMID: 2720895 No abstract available.
Systemic hypersensitivity reaction due to sulfadiazin.
Volckaert A, De Bruyne R, Van der Niepen P, Cauchie P, Van Belle S. Volckaert A, et al. Acta Clin Belg. 1987;42(5):381-3. doi: 10.1080/22953337.1987.11719251. Acta Clin Belg. 1987. PMID: 3425124 No abstract available.
Lack of effect of aprepitant on the pharmacokinetics of docetaxel in cancer patients.
Nygren P, Hande K, Petty KJ, Fedgchin M, van Dyck K, Majumdar A, Panebianco D, de Smet M, Ahmed T, Murphy MG, Gottesdiener KM, Cocquyt V, van Belle S. Nygren P, et al. Cancer Chemother Pharmacol. 2005 Jun;55(6):609-16. doi: 10.1007/s00280-004-0946-3. Epub 2005 Feb 19. Cancer Chemother Pharmacol. 2005. PMID: 15723220 Clinical Trial.
Comparison of the anti-emetic efficacy of different doses of ondansetron, given as either a continuous infusion or a single intravenous dose, in acute cisplatin-induced emesis. A multicentre, double-blind, randomised, parallel group study. Ondansetron Study Group.
Seynaeve C, Schuller J, Buser K, Porteder H, Van Belle S, Sevelda P, Christmann D, Schmidt M, Kitchener H, Paes D, et al. Seynaeve C, et al. Br J Cancer. 1992 Jul;66(1):192-7. doi: 10.1038/bjc.1992.241. Br J Cancer. 1992. PMID: 1386245 Free PMC article. Clinical Trial.
125 results